Waters Corporation Accrued Expenses

Accrued Expenses of WAT for past 10 years: annual, quarterly and twelve month trailing (TTM) including Accrued Expenses growth rates and interactive chart. Accrued expense is expense which has been incurred but not yet paid. Expense must be recorded in the accounting period in which it is incurred. Therefore, accrued expense must be recognized in the accounting period in which it occurs rather than in the following period in which it will be paid.


Highlights and Quick Summary

  • Accrued Expenses for the quarter ending December 30, 2020 was $83.1 Million (a 47.69% increase compared to previous quarter)
  • Year-over-year quarterly Accrued Expenses increased by 146.9%
  • Annual Accrued Expenses for 2020 was $83.1 Million (a 49.94% increase from previous year)
  • Annual Accrued Expenses for 2019 was $55.4 Million (a -27.87% decrease from previous year)
  • Annual Accrued Expenses for 2018 was $76.8 Million (a -6.34% decrease from previous year)
Visit stockrow.com/WAT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Accrued Expenses of Waters Corporation

Most recent Accrued Expensesof WAT including historical data for past 10 years.

Interactive Chart of Accrued Expenses of Waters Corporation

Waters Corporation Accrued Expenses for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $83.12 $56.28 $43.44 $33.66 $83.12
2019 $55.43 $62.53 $57.92 $68.23 $55.43
2018 $76.85 $52.05 $49.23 $44.42 $76.85
2017 $82.05 $54.88 $47.0 $42.87 $82.05
2016 $70.86 $54.99 $48.51 $43.78 $70.86
2015 $68.0 $52.92 $37.46 $41.82 $68.0
2014 $60.46 $46.96 $43.09 $39.5 $60.46
2013 $56.27 $42.19 $38.64 $37.03 $56.27
2012 $44.26 $39.85 $38.72 $40.02 $44.26
2011 $63.21 $51.71 $44.63 $40.6 $63.21
2010 $64.1 $49.24 $41.64 $64.1

Business Profile of Waters Corporation

Sector: Healthcare
Industry: Diagnostics & Research
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company has a collaboration with Genovis AB to develop and market biopharmaceutical characterization workflows based on the its BioAccord LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.